Aguilera, Oscar

Targeting KRAS Mutant CMS3 Subtype by Metabolic Inhibitors. [electronic resource] - Advances in experimental medicine and biology - 23-34 p. digital

Publication Type: Journal Article; Review

0065-2598

10.1007/978-3-030-02771-1_3 doi


Cell Line, Tumor
Colorectal Neoplasms--drug therapy
Drug Resistance, Neoplasm--genetics
Genes, ras
Humans
Molecular Targeted Therapy
Mutation
Proto-Oncogene Proteins p21(ras)--genetics